Member portal ...

Join or renew today Membership portal

Calendar

Reporting on the care and costs of diabetes

02/16/22    

webcast

SAVE THE DATE: Feb. 16, 1 p.m. ET

High costs for doctor's visits, medications and supplies force many diabetes patients to forgo or delay routine care. Patients and lawmakers have expressed outrage at the rising price of insulin, which Type 1 diabetes patients must take their entire lives and is sometimes required to keep Type 2 patients’ disease under control. Last month, the National Clinical Care Commission endorsed limiting insulin price increases to the rate of inflation.

Experts in the care and costs of diabetes will debate the need for a more comprehensive approach to this deadly disease and outline some of the ways the U.S. health care system can make care for patients with diabetes more affordable.

View the webcast


Karen Van Nuys

Ted Doolittle

Sanjoy Dutta

Estelle Everett

Joseph Burns

  • Karen Van Nuys, Ph.D., focuses on funding in the pharmaceutical supply chain and the effect of commercial practices such as copay coupons and copay clawbacks on the cost of prescription drugs. Her work has been published in leading journals in economics, medicine, finance and health policy. In addition to her work at the USC Schaeffer Center, she is also a research assistant professor at the USC Price School of Public Policy.

  • Ted Doolittle is an attorney and former federal prosecutor who has had a long career in health care, legal practice and law enforcement, including service as the Deputy Director of the Center for Program Integrity at federal Centers for Medicare and Medicaid Service (CMS). In this role, Doolittle had oversight of Medicare and Medicaid health care fraud investigations and was responsible for leading the implementation of a variety of programs under the Affordable Care Act.

  • Sanjoy Dutta, Ph.D., is the chief scientific officer at JDRF where he oversees all of JDRF’s efforts to cure Type 1 diabetes, including beta cell therapies, immunotherapies, glucose control and complications. Before joining JDRF in 2009, Dutta was the associate director of translational medicine and clinical biomarkers at Bristol-Myers Squibb and principal scientist of cardiovascular and metabolic diseases at Hoffmann-La Roche.

  • Estelle Everett, M.D., is an endocrinologist and health services researcher at the Geffen School of Medicine at UCLA. Her research involves addressing the barriers to care among patients with diabetes, inequities in diabetes care and outcomes and the disparities in access to diabetes treatment for vulnerable populations with Type 1 diabetes. She completed medical degree at UCLA and then completed her Internal Medicine residency and Endocrinology fellowship at Johns Hopkins University.